Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
71.180
Open
67.690
VWAP
69.16
Vol
1.13M
Mkt Cap
3.58B
Low
65.040
Amount
78.12M
EV/EBITDA(TTM)
26.47
Total Shares
50.67M
EV
3.39B
EV/OCF(TTM)
--
P/S(TTM)
6.87
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
Show More
AI Stock Picker

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
128.12M
+3.52%
0.498
+8.17%
144.47M
+5.12%
0.545
+4.85%
144.94M
+9.08%
0.562
+8.01%
Estimates Revision
The market is revising No Change the revenue expectations for Exponent, Inc. (EXPO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 0.33%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+0.33%
In Past 3 Month
4 Analyst Rating
Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is 76.50 USD with a low forecast of 76.00 USD and a high forecast of 77.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 70.810
sliders
Low
76.00
Averages
76.50
High
77.00
UBS
Neutral
downgrade
$84 -> $76
2025-08-01
Reason
UBS lowered the firm's price target on Exponent to $76 from $84 and keeps a Neutral rating on the shares.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Exponent Inc (EXPO.O) is 32.26, compared to its 5-year average forward P/E of 47.48. For a more detailed relative valuation and DCF analysis to assess Exponent Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
47.48
Current PE
32.26
Overvalued PE
55.55
Undervalued PE
39.41

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average EV/EBITDA
33.62
Current EV/EBITDA
21.86
Overvalued EV/EBITDA
39.35
Undervalued EV/EBITDA
27.89

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average PS
10.07
Current PS
70.81
Overvalued PS
14.19
Undervalued PS
5.95
Financial AI Agent

Financials

Annual
Quarterly
FY2025Q3
YoY :
+9.58%
137.07M
Total Revenue
FY2025Q3
YoY :
+12.35%
29.04M
Operating Profit
FY2025Q3
YoY :
+7.68%
28.04M
Net Income after Tax
FY2025Q3
YoY :
+10.00%
0.55
EPS - Diluted
FY2025Q2
YoY :
-28.07%
33.95M
Free Cash Flow
FY2025Q3
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q3
YoY :
-100.00%
N/A
FCF Margin - %
FY2025Q3
YoY :
-1.73%
20.46
Net Margin - %
FY2025Q3
YoY :
-7.36%
25.79
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
672.3K
USD
2
3-6
Months
460.7K
USD
2
6-9
Months
489.1K
USD
3
0-12
Months
149.2K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
9.4K
Volume
3
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
3
18.3K
Volume
Months
0-12
1
10.8K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
8.0K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
32.5K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
8.0K
USD
Months
6-9
2
65.0K
USD
Months
0-12
2
65.0K
USD
Months
Intellectia AI SwingMax

EXPO News & Events

Events Timeline

2025-10-30 (ET)
2025-10-30
16:19:05
Exponent anticipates low single-digit revenue growth before reimbursements for FY25.
select
2025-10-30
16:18:30
Exponent anticipates low to mid single-digit revenue growth in Q4 prior to reimbursements.
select
2025-10-30
16:17:36
Exponent Announces Q3 EPS of 55c, Exceeding Consensus of 53c
select
Sign Up For More Events

News

9.5
10-30NASDAQ.COM
Exponent (EXPO) Surpasses Q3 Earnings and Revenue Projections
8.0
10-27NASDAQ.COM
Significant Options Activity on Monday: RCL, EXPO, BURL
3.0
09-22NASDAQ.COM
Three Stocks to Explore in the Thriving Consulting Services Sector
Sign Up For More News

FAQ

arrow icon

What is Exponent Inc (EXPO) stock price today?

The current price of EXPO is 70.81 USD — it has increased 5.97 % in the last trading day.

arrow icon

What is Exponent Inc (EXPO)'s business?

arrow icon

What is the price predicton of EXPO Stock?

arrow icon

What is Exponent Inc (EXPO)'s revenue for the last quarter?

arrow icon

What is Exponent Inc (EXPO)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Exponent Inc (EXPO)'s fundamentals?

arrow icon

How many employees does Exponent Inc (EXPO). have?

arrow icon

What is Exponent Inc (EXPO) market cap?